|Day Low/High||0.43 / 0.49|
|52 Wk Low/High||0.44 / 2.12|
Rite Aid said it expects its pharmacy sourcing deal with McKesson as well as new and higher-priced generic drugs to drive sales in 2015.
Futures point lower; GM makes a move as recall probe widens.
The largest and third-largest drugstore chains reported a drop in front-end sales which were offset by an increase in pharmacy and prescription drug income.
Jim Cramer says following the recession, 'people just are not spending the way that they used to' and investors can take advantage of this thesis by looking at Cedar Fair and Six Flags.
I've been pleasantly surprised by my conversations with folks at my recent book signings.
Shares of Rite Aid are down after the company lowered its profit forecast and revenue outlook for the year.
Against this difficult backdrop, insider activity can serve as a useful guide for our next move.
Some of the worst charts in the market right now belong to some high-profile retailers.
Stocks are moving higher as the Fed said it will keep buying bonds. Rite Aid is up and Pier One is down, Take Two is a steal.
The biggest event next week will be the Federal Reserve meeting, when it will address tapering of its bond-buying program.
The stock has risen fast, but the company's balance sheet should inspire fear.
Drugstore retailer Walgreen will likely boost its dividend in July, says Portfolio Manager David Peltier.